Evidence map›Paper›PMID 42662715›Full record

ArticleNeurology. Genetics2026

Mortality of Individuals With

Yuan Lian, Keisi Kotobelli, Katie Glisic, Daniel A Sprague, Sonia M Vallabh, Brian S Appleby, Eric Vallabh Minikel

Abstract read
In one paragraph

Article in Neurology. Genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Yuan LianProgram in Brain Health, Broad Institute of MIT and Harvard, Cambridge, MA.ORCID https://orcid.org/0009-0001-9565-2292
Keisi KotobelliNational Prion Disease Pathology Surveillance Center, Case Western Reserve University, Cleveland, OH; and.ORCID https://orcid.org/0009-0009-9021-8348
Katie GlisicNational Prion Disease Pathology Surveillance Center, Case Western Reserve University, Cleveland, OH; and.ORCID https://orcid.org/0009-0001-8548-2461
Daniel A SpragueProgram in Brain Health, Broad Institute of MIT and Harvard, Cambridge, MA.ORCID https://orcid.org/0009-0003-1355-0298
Sonia M VallabhProgram in Brain Health, Broad Institute of MIT and Harvard, Cambridge, MA.ORCID https://orcid.org/0000-0003-3824-2702
Brian S ApplebyNational Prion Disease Pathology Surveillance Center, Case Western Reserve University, Cleveland, OH; and.ORCID https://orcid.org/0000-0003-2275-3292
Eric Vallabh MinikelProgram in Brain Health, Broad Institute of MIT and Harvard, Cambridge, MA.ORCID https://orcid.org/0000-0003-2206-1608

Funding

Biomarkers and Mechanisms of PrP Misfolding, Mutation, and DeficiencyR01NS132022 · NINDS · BROAD INSTITUTE, INC. · PI Eric Vallabh Minikel · 2024 to 2026
$1.9M
NINDS NIH HHS R01 NS132022
6 · The paper itself

Abstract

Background and Objectives: To characterize the survival of individuals with pathogenic Methods: In this single-center cohort study, we gathered data on individuals who received positive antemortem Results: Four hundred four individuals received positive genetic test results. Of 206 cases symptomatic at the time of genetic testing, 188 are likely now deceased based on typical disease duration for their genetic variants. Combined autopsy and public record searches in combination confirmed 174 of these deaths, for an estimated 92.6% sensitivity. We evaluated the age-dependent penetrance of the reportedly highly penetrance variants D178N and E200K and the reportedly low-penetrance variant V210I. Among 99 initially asymptomatic individuals with the pathogenic E200K variant, more than 936 person-years of follow-up, 18 deaths were observed, significantly fewer than 27.4 expected according to life tables based on retrospective data. The age-dependent penetrance of E200K calculated from these longitudinal data was significantly lower than that from retrospective data, with 69% penetrance by age 80 and a median age at death of 75. For the pathogenic D178N variant, the median age at death was 57, which was numerically later, but not significantly different from, that seen in retrospective data. For V210I, just 2 deaths occurred, both after age 90, consistent with minimal penetrance. Discussion: Our data support high penetrance of

Identifiers

PMID42662715
PMCPMC13520194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.